Ercros, S.A. (BME:ECR)

Market Cap	257.39M
Revenue (ttm)	654.67M
Net Income (ttm)	-42.32M
Shares Out	91.44M
EPS (ttm)	-0.47
PE Ratio	n/a
Forward PE	n/a
Dividend	0.10 (3.41%)
Ex-Dividend Date	n/a

Volume	14,967
Average Volume	85,285
Open	2.820
Previous Close	2.815
Day's Range	2.790 - 2.820
52-Week Range	2.580 - 3.810
Beta	0.76
RSI	42.89
Earnings Date	Aug 28, 2025

About Ercros

Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers and polychloride. This segment’s prod...

• Industry: Chemicals
• Sector: Materials
• Founded: 1817
• Employees: 1,318
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ECR